HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Waki Selected Research

Hypoxia (Hypoxemia)

12/2001Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.
1/2001Greater resistance and lower contribution of free radicals to hypoxic neurotoxicity in immature rat brain compared to adult brain as revealed by dynamic changes in glucose metabolism.
8/2000Posthypoxic reoxygenation-induced neurotoxicity prevented by free radical scavenger and NMDA/non-NMDA antagonist in tandem as revealed by dynamic changes in glucose metabolism with positron autoradiography.
5/2000Neurotoxicity after hypoxia/during ischemia due to glutamate with/without free radicals as revealed by dynamic changes in glucose metabolism.
2/2000Hypoxic but not ischemic neurotoxicity of free radicals revealed by dynamic changes in glucose metabolism of fresh rat brain slices on positron autoradiography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Waki Research Topics

Disease

5Neoplasms (Cancer)
12/2001 - 10/2000
5Hypoxia (Hypoxemia)
12/2001 - 02/2000
2Ischemia
05/2000 - 02/2000
1Ehrlich Tumor Carcinoma
12/2001
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2001
1Brain Neoplasms (Brain Tumor)
04/2001
1Hypothermia
05/2000

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
04/2001 - 02/2000
4Free RadicalsIBA
01/2001 - 02/2000
4N-Methylaspartate (NMDA)IBA
01/2001 - 02/2000
4Free Radical ScavengersIBA
01/2001 - 02/2000
3Neuroprotective AgentsIBA
01/2001 - 02/2000
2Excitatory Amino AcidsIBA
08/2000 - 05/2000
2Glutamic Acid (Glutamate)FDA Link
05/2000 - 02/2000
1NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA
12/2001
1copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
12/2001
1Cytochrome-B(5) Reductase (Methemoglobin Reductase)IBA
12/2001
1EnzymesIBA
12/2001
1NAD (NADH)IBA
12/2001
1Copper-62IBA
06/2001
1Indicators and Reagents (Reagents)IBA
04/2001
1UridineIBA
03/2001
1HexokinaseIBA
03/2001
1CarbonIBA
03/2001
1Cysteine (L-Cysteine)FDA Link
03/2001
1Methionine (L-Methionine)FDA Link
03/2001
1LipidsIBA
02/2001
1Phosphatidylcholines (Phosphatidylcholine)IBA
02/2001
1Acetates (Acetic Acid Esters)FDA Link
02/2001
1Dizocilpine Maleate (Dizocilpine)IBA
01/2001
1Oxygen (Dioxygen)IBA
02/2000

Therapy/Procedure

1Therapeutics
04/2001
1Radiotherapy
10/2000